A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
Status:
Terminated
Trial end date:
2011-06-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the analgesic efficacy, safety, and tolerability of
JNJ-42160443 compared to placebo in patients with moderate to severe, chronic bladder pain
from interstitial cystitis and/or painful bladder syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.